I’m a radiation oncologist and researcher with a particular interest in data science (biostatistics, data mining/machine learning), bioinformatics, molecular biomarkers, and radiomics. I focus on the implementation of artificial intelligence in oncology. My clinical interests focus on urinary (bladder, prostate), gastrointestinal (rectal), and thoracic cancers. I am listed in Harvard Catalyst as a Visiting Assistant Professor of Radiation Oncology in the Department of Radiation Oncology at Dana-Farber Cancer Institute in Boston, MA, USA.
Employment history
- Current appointment: Visiting Assistant Professor of Radiation Oncology, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- 2024 - present: Assistant Professor, Department of Biostatistics and Translational Medicine, Medical University of Lodz, Poland
- Supervisor of the “Artificial Intelligence in Oncology” Students’ Scientific Group.
- Lecturer in Biostatistics, Translational Medicine, Research Methodology, and AI, including data mining and deep learning.
- Engaged in cancer research, focusing on bioinformatics and omic data analysis (radiomics, NGS sequencing - miRNA-seq, bulk/sc RNA-seq, WXS).
- PI in ERA PerMed Consortium.
- 2023 - present: Radiation Oncologist, Deputy Head of Department of Brachytherapy and General Oncology, Regional Oncology Centre, Copernicus Memorial Hospital, Lodz, Poland
- Deputy supervisor of a 34-bed ward, managing treatments like radiation (both external beam RT and brachytherapy), chemoradiotherapy, chemotherapy, and immunotherapy.
- Actively treating patients with various types of cancer, specializing in urological, gastrointestinal, and lung cancers (see https://radioonkolog.pl for clinical activities). SI in commercial and non-commercial clinical trials.
- Performing stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS), radiochemotherapy, and radioimmunotherapy.
- 2022 - 2023: Research Fellow in Radiation Oncology (Mouw Lab and Carvalho Lab), Dana-Farber Cancer Institute/Harvard Medical School/Broad Institute of MIT and Harvard, Boston, MA, USA
- 2021 - 2023: Research and Teaching Assistant, Department of Biostatistics and Translational Medicine, Medical University of Lodz, Poland
- 2018 - 2023: Radiation Oncology Resident Physician, Regional Oncology Centre, Copernicus Memorial Hospital, Lodz, Poland
- Physician in Department of Radiotherapy and on-call physician in Radiotherapy and Oncology Ward (reference: Prof. Jacek Fijuth, M.D., Ph.D.),
- Additional experience as on-call physician in Hematooncology Ward (reference: Prof. Piotr Smolewski, M.D., Ph.D.).
- 2017 - 2018: Bioinformatics and Medical Informatics Specialist, Department of Biostatistics and Translational Medicine, Medical University of Lodz, Poland
- 2016 - 2017: Medical Post-graduate Internship, Clinical Hospital of the Ministry of the Interior and Administration in Lodz, Lodz, Poland
Education
- 2023: Board Certification (Radiation Oncology), Medical Examinations Center (CEM) in Poland;
- 2016 - 2021: Doctor of Philosophy (PhD) (doctorate), Department of Biostatistics and Translational Medicine (reference: Wojciech Fendler, M.D., Ph.D.; https://biostat.umed.pl):
- 2017: Obtaining the full medical license in Poland (PWZ: 3347648)
- 2010 - 2016: Doctor of Medicine (MD) (6-year M.D. Program; grade: very good), Faculty of Medicine, Medical University of Lodz (Poland)
Internships
- 2022-2023: Bekker NAWA (6 months) research fellowship in Dana-Farber Cancer Institute/Harvard Medical School/Broad Institute of MIT and Harvard, Boston, MA, USA (reference: Kent Mouw, M.D., Ph.D.)
- 2026: Prof. Franciszek Walczak NAWA scholarship for a 6-month research stay at Dana-Farber Cancer Institute/Harvard Medical School focused on bladder-sparing treatment strategies in bladder cancer.
- 2016: ERASMUS+ research internship at EPSRC Centre For Mathematical And Statistical Analysis Of Multimodal Clinical Imaging, University of Cambridge, Cambridge, UK (reference: Prof. John Aston, Ph.D.)
- 2015: IFMSA research exchange (6 weeks), Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), Upstate Medical University, Syracuse, NY, USA (reference: Stephen J. Glatt, Ph.D.)
- 2014: neurosurgical clinical clerkship (3 weeks), University Hospital Southampton NHS Trust, Southampton, UK (reference: Paul Grundy, M.D.)
- 2013: medical clinical clerkship (4 weeks), Mubarak Al Kabeer Hospital, Kuwait City, Kuwait (reference: Ibrahim T. Lasheen, M.D.)
Funded research projects
- 2023 - present: ERA PerMed Consortium (Joint Transnational Call 2022), miRPOC - miRNA as biomarkers in early detection and personalised treatment in ovarian cancer, ~1 000 000 EUR [Partner PI at Medical University of Lodz; consortium with Cancer Registry of Norway/Oslo University Hospital, German Cancer Research Center and Brigham and Women’s Hospital/Harvard Medical School]
- 2019 - 2022: NCN PRELUDIUM [ID:
UMO-2018/29/N/NZ5/02422], Deep artificial neural networks in the integration of the expression profile of circulating and intracellular miRNA molecules in pancreatic cancer patients. 209 860 PLN [PI]
- 2014 - 2015: Ministry of Science and Higher Education Generation of the Future [ID:
MNiSw/2014/DIR/379/GPII], PancreApp: application of the eight-dimensional Shepard approximation in the individualization of nutritional recommendations, with particular emphasis on chronic pancreatitis, PLN 37,800 [PI]
- 2017 - 2018: Specialist in bioinformatics and medical informatics (building an internet platform to collect data for the research purposes of the project) in the project “Lodz Program for HNSCC Prevention” [ID:
POWR.05.01.00-00-0011/16] co-financed by the European Union as part of the European Social Fund (European Social Fund, 1 792 260 PLN)
- 2019-2021: Researcher in the study “Predictive Biomarkers of Radiation Toxicity (PBRTox)” [ID:
POIR.04.04.00-00-2280/16] under the supervision of prof. Wojciech Fendler (Foundation for Polish Science; 1 999 651 PLN)
- 2014-2016: Researcher in the study “Profile of circulating microRNAs in the diagnosis of rare forms of diabetes” [ID:
2012/05/E/NZ5/02130] under the supervision of prof. Wojciech Fendler (NCN SONATA BIS; 1 489 800 PLN)
Patents and commercializations
Selected awards and scholarships
- 2022: Best biostatistics Ph.D. thesis in 2021 (Awarded by StatSoft Polska).
- 2022: Implementation Activity Award of Polish Ministry of Science, for work involving the implementation of a diagnostic tests based on free-circulating microRNAs into clinical practice.
- 2021: Scholarship of Polpharma Scientific Foundation for best Ph.D. students.
- 2020: Scholarship for the best Ph.D. students at the Medical University of Lodz.
- 2019: Scholarship for the best Ph.D. students at the Medical University of Lodz.
- 2018: Scholarship for the best Ph.D. students at the Medical University of Lodz.
- 2017: Scholarship for the best Ph.D. students at the Medical University of Lodz.
- 2016: Scholarship for the best Ph.D. students at the Medical University of Lodz.
- 2016: Scholarship of the City of Lodz for the best Ph.D. students.
- 2016: Winner of Adzuna’s Polish „Graduate of the Year” contest.
- 2015: Scholarship of Minister of Science and Higher Education & Minister of Health of Republic of Poland for outstanding achievements for students in the academic year 2015/2016.
- 2015: Scholarship of Marshal of the Lodzkie Region (highest degree)
- 2014: Distinction in a nationwide competition “Studencki Nobel” (Eng. “Student’s Nobel Prize”).
- 2014: Special Award for the Youngest Winner of the Session at the conference 10. International & 52. Polish Training & Scientific Medical Congress of Students’ Scientific Societies and Junior Doctors “Juvenes Pro Medicina” 2014 in Łódź (founder: Aldona Ochęcka-Szymańska M.D., Ph.D.)
- 2013: Scholarship of Minister of Science and Higher Education of Republic of Poland for outstanding achievements for students in the academic year 2013/2014;
Research
Bibliometrics
H-index according to Google Scholar: 19
(citations = 1092; papers/abstracts = 97)
Bibliometrics and Google Scholar generated publication list
The publication list below is generated from Google Scholar at build time and may include preprints, conference records, duplicates, or incomplete metadata. For formal review, use the PubMed/ORCID/OpenAlex links above as authoritative records.
- B Tomasik, M Jąkalski, M Bieńkowski, J Teodorczyk, BK Sobocki, … Non-invasive assessment of PD-L1 status and histology in non-small cell lung cancer using 18F-FDG PET/CT radiomics Journal of Translational Medicine 2026:24 (1), 587 [citations: 1]
- JW Webber, L Wollborn, S Mishra, S Alimena, B Testino, K Stawiski, … A lasso-based model combining miRNA and clinical variables predicts future risk of breast and ovarian cancer Scientific Reports 2026: [citations: 0]
- K Kuna, J Burzyński, D Mikulski, B Sobocki, A Papis-Ubych, K Stawiski, … Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy Contemporary Oncology/Współczesna Onkologia 2026:29 (1) [citations: 0]
- M Golinska, A Rycerz, M Sobczak, J Chrzanowski, K Stawiski, W Fendler Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors—a network meta-analysis Frontiers in Immunology 2025:16, 1619434 [citations: 12]
- FLF Carvalho, J Lee, N Kalavros, Y Zhou, D Michaud, I Stelter, H Siddiqui, … Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer bioRxiv 2025:2025.09. 08.674862 [citations: 0]
- D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating microrna signatures for ovarian cancer US Patent 2025:12,385,099 [citations: 0]
- K Stawiski, A der Rycerz, J Burzyński, K Kasper, W Fendler 4567 Radonek-Fine-Tuned GPT-4o for Radiation Oncology Patient Support: Preliminary Evaluation and Protocol for Prospective Validation Radiotherapy and Oncology 2025:206, S2417-S2418 [citations: 0]
- M Pajdziński, J Burzyński, A Zięba, N Jędrzejczak, J Fijuth, K Stawiski 4474 Risk of Neutropenia With or Without Daratumumab in Bortezomib-Based First-Line Chemotherapy and Radiotherapy for Multiple Myeloma: A Pilot Study Radiotherapy and Oncology 2025:206, S919-S920 [citations: 0]
- D Chowdhury, W Fendler, K Stawiski Circulating microrna signatures for pancreatic cancer US Patent App. 2025:18/577,387 [citations: 0]
- K Stawiski, J Perera-Bel, A Rodriguez-Vida, N Juanpere Rodero, J Lee, … Tumor B cell infiltration in platinum-treated advanced urothelial carcinoma bioRxiv 2025:2025.02. 27.640395 [citations: 0]
- MM Pietrzak, W Pietruszewska, M Barańska, A Rycerz, K Stawiski, … Assessment of the Interdependencies Between High-Speed Videoendoscopy and Simultaneously Recorded Audio Data in Various Glottal Pathologies Biomedicines 2025:13 (2), 511 [citations: 0]
- S Kołowacik, BJ Bińkowski, K Stawiski, J Drożdż Time efficiency and safety of antazoline in the rapid cardioversion of recent onset atrial fibrillation during supraventricular arrhythmias ablation Polish Heart Journal (Kardiologia Polska) 2025:83 (2), 203-206 [citations: 0]
- Z Nowicka, K Kuna, M Łaszczych, M Łazar-Poniatowska, BK Sobocki, … Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniques Physics and Imaging in Radiation Oncology 2024:30, 100593 [citations: 12]
- P Brady, A Yousif, N Sasamoto, AF Vitonis, W Fendler, K Stawiski, … Plasma microRNA expression in adolescents and young adults with endometriosis: the importance of hormone use Frontiers in Reproductive Health 2024:6, 1360417 [citations: 8]
- A Puła, T Robak, I Dróżdż, K Stawiski, A Rycerz, M Misiewicz, P Robak Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens–pilot study Leukemia & Lymphoma 2024:65 (2), 257-264 [citations: 4]
- Z Nowicka, K Kuna, M Łaszczych, K Stawiski, B Tomasik, W Fendler Effect of the time-of-day of radiotherapy administration on radiation-induced lymphocyte depletion in lung cancer International Journal of Radiation Oncology, Biology, Physics 2024:120 (2), e52 [citations: 3]
- K Stawiski, RT Fortner, L Pestarino, SU Umu, R Kaaks, TB Rounge, … Validation of miRNA signatures for ovarian cancer earlier detection in the pre-diagnosis setting using machine learning approaches Frontiers in oncology 2024:14, 1389066 [citations: 3]
- JW Webber, L Wollborn, S Mishra, AF Vitonis, DW Cramer, RT Phan, … Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass Gynecologic Oncology 2024:190, 124-130 [citations: 1]
- K Stawiski, M Bilski, J Nowak-Potemska, M Bilewicz, J Fijuth Radiation induced lymphopenia depends on lymph node irradiation in prostate cancer radiotherapy International Journal of Radiation Oncology, Biology, Physics 2024:120 (2), e549-e550 [citations: 1]
- D Mikulski, M Nowicki, I Dróżdż, E Perdas, P Strzałka, K Kościelny, … MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation Biomarker Research 2024:12 (1), 42 [citations: 1]
- Z Nowicka, K Kuna, K Stawiski, J Sołek, M Świderek, A Papis‐Ubych, … Extreme acute radiation‐induced toxicity in a patient with polymorphous low‐grade adenocarcinoma of the nasopharynx and rare variants in DNA repair genes Head & Neck 2024:46 (2), E10-E17 [citations: 1]
- K Stawiski, M Pajdziński, A Zięba, M Masłowski, J Fijuth 3178: Development of a CT-only autosegmentation model for hippocampal delineation in radiation therapy. Radiotherapy and Oncology 2024:194, S3165-S3166 [citations: 0]
- M Masłowski, K Stawiski, A Zięba, D Mikulski, J Bednarek, J Fijuth 1994: Predicting neutropenia dynamics after RT in first-line Bortezomib-based chemo for MM-a pilot study Radiotherapy and Oncology 2024:194, S1165-S1168 [citations: 0]
- F Mohammed, K Stawiski, HS Musa, SK Owolabi, S Abubakar, SO Rotimi, … Co-expression of HERV-R, CCND1, BRAF, FOXA1, TMPRSS2, ATF4 and low expression of BAZ1B and KMT2D is associated with early detection and poor prognosis of prostate cancer in … Cancer Research 2024:84 (6_Supplement), 6432-6432 [citations: 0]
- FLF De Carvalho, J Lee, K Bi, B Titchen, K Stawiski, J Park, A Garza, … Tumor-immune interactions and cisplatin resistance in localized muscle-invasive bladder cancer Cancer Research 2024:84 (6_Supplement), 7041-7041 [citations: 0]
- CJ Magnani, VD DAndrea, K Stawiski, I Stelter, T Hanlon, L Jia, AS Kibel, … AIRD1A knockouts in bladder cancer cell lines leads to MYC and E2F activation implicated in more aggressive tumor behavior European Urology 2024:85, S219-S220 [citations: 0]
- A Suleja, M Bliski, E Laukhtina, P Rajwa, K Stawiski, M Miszczyk Radioterapia stereotaktyczna (SBRT) w leczeniu pierwotnie zlokalizowanego raka nerkowokomórkowego (RCC)-przegląd systematyczny i metaanaliza Biuletyn Polskiego Towarzystwa Onkologicznego NOWOTWORY 2024:9 (Suppl. 1) [citations: 0]
- Z Nowicka, K Kuna, M Łaszczych, M Łazar-Poniatowska, BK Sobocki, … Physics and Imaging in Radiation Oncology Oncology 2024:30 [citations: 0]
- BA Łochowska, K Stawiski, K Kuna, Z Nowicka, M Łochowski, J Fijuth Predicting overall survival in non-small cell lung cancer patients receiving concurrent radiochemotherapy and adjuvant durvalumab–a Polish real-world single-center experience Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2024:9 (3), 190-196 [citations: 0]
- M Miszczyk, Ł Magrowski, T Krzysztofiak, R Stando, W Majewski, … Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group … Radiotherapy and Oncology 2023:183, 109632 [citations: 29]
- Y Zhou, J Börcsök, E Adib, SC Kamran, AJ Neil, K Stawiski, D Freeman, … ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer Science advances 2023:9 (47), eadg2263 [citations: 24]
- K Elias, U Smyczynska, K Stawiski, Z Nowicka, J Webber, J Kaplan, … Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles Nature communications 2023:14 (1), 3350 [citations: 20]
- Z Nowicka, B Tomasik, D Kozono, K Stawiski, T Johnson, D Haas-Kogan, … Serum miRNA-based signature indicates radiation exposure and dose in humans: a multicenter diagnostic biomarker study Radiotherapy and Oncology 2023:185, 109731 [citations: 12]
- J Malinowski, W Pietruszewska, K Stawiski, MM Pietrzak, M Barańska, … High-speed videoendoscopy enhances the objective assessment of glottic organic lesions: a case-control study with multivariable data-mining model development Cancers 2023:15 (14), 3716 [citations: 5]
- M Masłowski, K Stawiski, A Zięba, D Mikulski, J Bednarek, J Fijuth Predicting neutropenia dynamics after radiation therapy in multiple myeloma patients receiving first-line bortezomib-based chemotherapy–a pilot study Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2023:8 (4), 274-283 [citations: 1]
- K Stawiski, J Perera-Bel, A Rodriguez-Vida, NJ Rodero, KW Mouw, … Assessing tumor-infiltrating immune cells and outcomes with cisplatin-versus carboplatin-based treatment in advanced urothelial cancer (UC): Survival analysis of three platinum … Journal of Clinical Oncology 2023:41 (16_suppl), 4583-4583 [citations: 0]
- M Jobczyk, K Stawiski, M Kaszkowiak, P Rajwa, W Różański, F Soria, … Deep learning-based recalibration of the CUETO and EORTC prediction tools for recurrence and progression of non–muscle-invasive bladder cancer European urology oncology 2022:5 (1), 109-112 [citations: 36]
- K Mieczkowski, K Kitowska, M Braun, B Galikowska‐Bogut, … FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer Molecular Oncology 2022:16 (15), 2823-2842 [citations: 22]
- Ł Kuncman, M Orzechowska, K Stawiski, M Masłowski, M Ciążyńska, … The kinetics of FMS-related tyrosine kinase 3 ligand (Flt-3L) during chemoradiotherapy suggests a potential gain from the earlier initiation of immunotherapy Cancers 2022:14 (16), 3844 [citations: 17]
- M Panek, K Stawiski, M Kaszkowiak, P Kuna Cytokine TGFβ gene polymorphism in asthma: TGF-related SNP analysis enhances the prediction of disease diagnosis (a case-control study with multivariable data-mining model … Frontiers in immunology 2022:13, 746360 [citations: 14]
- K Stawiski, M Kaszkowiak, D Mikulski, P Hogendorf, A Durczyński, … OmicSelector: automatic feature selection and deep learning modeling for omic experiments BioRxiv 2022:2022.06. 01.494299 [citations: 12]
- W Fendler, B Tomasik, K Atkins, K Stawiski, J Chałubińska-Fendler, … The clinician’s guide to radiotherapy complications Polskie Archiwum Medycyny Wewnętrznej 2022:132 (1) [citations: 10]
- A Gockley, K Pagacz, S Fiascone, K Stawiski, N Holub, K Hasselblatt, … A translational model to improve early detection of epithelial ovarian cancers Frontiers in Oncology 2022:12, 786154 [citations: 8]
- M Miszczyk, J Rembak-Szynkiewicz, Ł Magrowski, K Stawiski, … The prognostic value of PI-RADS score in CyberKnife ultra-hypofractionated radiotherapy for localized prostate cancer Cancers 2022:14 (7), 1613 [citations: 8]
- EJ Bobeff, M Bukowiecka-Matusiak, K Stawiski, K Wiśniewski, … Plasma amino acids may improve prediction accuracy of cerebral vasospasm after aneurysmal subarachnoid haemorrhage Journal of Clinical Medicine 2022:11 (2), 380 [citations: 6]
- S Kubik, D Jesionek-Kupnicka, K Stawiski, J Fijuth, … Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma Journal of Obstetrics and Gynaecology 2022:42 (6), 2248-2254 [citations: 5]
- EJ Bobeff, K Stawiski, PA Stanisławska, BJ Posmyk, K Wiśniewski, M Bryl, … Validation of the elderly traumatic brain injury score: observational case control study World neurosurgery 2022:161, e464-e472 [citations: 5]
- D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating microRNA signatures for ovarian cancer US Patent 2022:11,214,839 [citations: 3]
- M Miszczyk, E Staniewska, I Jabłońska, A Lipka-Rajwa, K Stawiski, … Volumetric staging in radiotherapy for oropharyngeal cancers Tumori Journal 2022:108 (6), 586-591 [citations: 0]
- K Stawiski, M Maslowski, W Maslowska, M Kordzinska, B Lochowska, … Clinical and Radiomics-Based Deep Learning Predictive Model for Early Treatment Failure after Neoadjuvant Radiochemotherapy for Rectal Cancer International Journal of Radiation Oncology, Biology, Physics 2022:114 (3), e150 [citations: 0]
- M Miszczyk, J Ciepał, R Stando, O Masri, I Jabłońska, K Stawiski, … The Association between Dose Escalation and Risk of Developing Metastases in Intermediate and High-Risk Prostate Cancer Patients Treated with Radiotherapy International Journal of Radiation Oncology, Biology, Physics 2022:114 (3), e231 [citations: 0]
- A Napieralska, J Bochenek-Cibor, A Chyrek, M Konkol, E Pawłowska, … Improving Education in Radiation Oncology in Poland International Journal of Radiation Oncology, Biology, Physics 2022:114 (1), e4-e5 [citations: 0]
- D Mikulski, M Nowicki, I Dróźdż, E Perdas, P Strzałka, K Kościelny, … Serum miRNA-based neural network models for predicting complications in patients receiving high-dose melphalan or BeEAM conditioning chemotherapy. Acta Haematologica Polonica 2022:53 [citations: 0]
- M Panek, K Stawiski, M Kaszkowiak, P Kuna Cytokine TGFβ gene polymorphisms in asthma Frontiers in Immunology 2022:13 [citations: 0]
- EJ Bobeff, M Bukowiecka-Matusiak, K Stawiski, K Wiśniewski, … Plasma Amino Acids May Improve Prediction Accuracy of Cerebral Vasospasm after Aneurysmal Subarachnoid Haemorrhage Journal of Clinical Medicine 2022:11 (2), 380 [citations: 0]
- P Robak, D Jarych, D Mikulski, I Dróżdż, E Węgłowska, A Kotkowska, … The prognostic value of whole-blood PSMB5, CXCR4, POMP, and RPL5 mRNA expression in patients with multiple myeloma treated with bortezomib Cancers 2021:13 (5), 951 [citations: 23]
- B Tomasik, A Papis-Ubych, K Stawiski, J Fijuth, P Kędzierawski, … Serum microRNAs as xerostomia biomarkers in patients with oropharyngeal cancer undergoing radiation therapy International Journal of Radiation Oncology Biology* Physics 2021:111 (5), 1237-1249* [citations: 18]
- P Michał, S Konrad, K Piotr TGF-β gene polimorphisms as risk factors for asthma control among clinic patients Journal of Inflammation 2021:18 (1), 28 [citations: 13]
- L Lee, B Howitt, T Cheng, M King, K Stawiski, W Fendler, D Chowdhury, … MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma Gynecologic oncology 2021:163 (3), 453-458 [citations: 9]
- D Mikulski, I Dróżdż, E Perdas, K Stawiski, M Nowicki, M Misiewicz, … Changes in the microrna expression profile in patients undergoing autologous steam cell transplantation Blood 2021:138, 4789 [citations: 5]
- M Miszczyk, W Majewski, K Stawiski, K Rasławski, P Rajwa, I Jabłońska, … Prognostic factors in postoperative radiotherapy for prostate cancer–tertiary center experience Radiology and Oncology 2021:55 (2), 203 [citations: 4]
- Z Nowicka, R Bibik, R Stando, W Fendler, K Stawiski, B Tomasik A link between seasonality and radiation-related toxicity: The big time or time will tell? Radiotherapy and Oncology 2021:161, 257-258 [citations: 2]
- ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … Correction to: A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence BMC genomics 2021:22 (1), 327-327 [citations: 1]
- ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence (vol 19, 37 … BMC GENOMICS 2021:22 (1) [citations: 0]
- B Małachowska, B Tomasik, K Stawiski, S Kulkarni, C Guha, … Circulating microRNAs as biomarkers of radiation exposure: a systematic review and meta-analysis International Journal of Radiation Oncology Biology* Physics 2020:106 (2), 390-402* [citations: 64]
- M Jobczyk, K Stawiski, W Fendler, W Różański Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non–muscle‐invasive bladder cancer (NMIBC … Cancer Medicine 2020:9 (11), 4014-4025 [citations: 59]
- P Robak, I Dróżdż, D Jarych, D Mikulski, E Węgłowska, M Siemieniuk-Ryś, … The value of serum microRNA expression signature in predicting refractoriness to bortezomib-based therapy in multiple myeloma patients Cancers 2020:12 (9), 2569 [citations: 28]
- Ł Kuncman, K Stawiski, M Masłowski, J Kucharz, J Fijuth Dose–volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer Strahlentherapie und Onkologie 2020:196 (11), 998-1005 [citations: 27]
- M Braun, D Piasecka, B Tomasik, K Mieczkowski, K Stawiski, A Zielinska, … Hormonal receptor status determines prognostic significance of FGFR2 in invasive breast carcinoma Cancers 2020:12 (9), 2713 [citations: 17]
- Z Nowicka, B Tomasik, DE Kozono, K Stawiski, TJ Johnson, … Serum Circulating MicroRNAs as Functional Biodosimeters in Patients Undergoing Total Body Irradiation International Journal of Radiation Oncology, Biology, Physics 2020:108 (3), e536 [citations: 0]
- Z Nowicka, K Stawiski, B Tomasik, W Fendler Extracellular miRNAs as biomarkers of head and neck cancer progression and metastasis International journal of molecular sciences 2019:20 (19), 4799 [citations: 45]
- A Zmyslowska, A Waszczykowska, D Baranska, K Stawiski, M Borowiec, … Optical coherence tomography and magnetic resonance imaging visual pathway evaluation in Wolfram syndrome Developmental Medicine & Child Neurology 2019:61 (3), 359-365 [citations: 27]
- EJ Bobeff, J Fortuniak, B Bryszewski, K Wiśniewski, M Bryl, K Kwiecień, … Mortality after traumatic brain injury in elderly patients: a new scoring system World neurosurgery 2019:128, e129-e147 [citations: 26]
- M Kotlicka-Antczak, MS Karbownik, K Stawiski, A Pawełczyk, N Żurner, … Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state European Psychiatry 2019:58, 72-79 [citations: 26]
- M Zakrzewska, R Gruszka, K Stawiski, W Fendler, J Kordacka, … Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors BMC cancer 2019:19 (1), 544 [citations: 16]
- EJ Bobeff, BJ Posmyk, K Bobeff, J Fortuniak, K Wiśniewski, K Stawiski, … Predicting outcome and conservative treatment failure in patients with skull fracture after traumatic brain injury: a retrospective cohort study Journal of Neurological Surgery Part A: Central European Neurosurgery 2019:80 (06 … [citations: 5]
- L Kuncman, K Stawiski, M Maslowski, J Wilczynska, J Bury, J Fijuth FT3-L Dynamics in Blood Could be Predictive of Time of Occurrence Lymphocyte Nadir in Patients Undergoing Preoperative Chemoradiotherapy for Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics 2019:105 (1), E167-E168 [citations: 0]
- ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced … BMC genomics 2018:19 (1), 37 [citations: 61]
- K Pagacz, K Stawiski, A Szadkowska, W Mlynarski, W Fendler GlyCulator2: an update on a web application for calculation of glycemic variability indices Acta diabetologica 2018:55 (8), 877-880 [citations: 37]
- A Puła, K Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized … Leukemia & Lymphoma 2018:59 (5), 1084-1094 [citations: 24]
- K Stawiski, I Pietrzak, W Młynarski, W Fendler, A Szadkowska NIRCa: An artificial neural network‐based insulin resistance calculator Pediatric Diabetes 2018:19 (2), 231-235 [citations: 15]
- KM Elias, W Fendler, K Stawiski, SJ Fiascone, AF Vitonis, RS Berkowitz, … Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer elife 2017:6, e28932 [citations: 174]
- J Trelinska, I Dachowska, D Baranska, K Stawiski, K Kotulska, W Fendler, … Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis (the EMINENTS study) Pediatric blood & cancer 2017:64 (6), e26347 [citations: 37]
- K Stawiski, J Trelińska, D Baranska, I Dachowska, K Kotulska, S Jóźwiak, … What are the true volumes of SEGA tumors? Reliability of planimetric and popular semi-automated image segmentation methods Magnetic Resonance Materials in Physics, Biology and Medicine 2017:30 (4), 397-405 [citations: 9]
- KM Elias, W Fendler, K Stawiski, SJ Fiascone, AF Vitonis, RS Berkowitz, … Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife eLife Sciences Publications Limited 2017:6, e28932 [citations: 6]
- A Pula, K Stawiski, M Braun, E Iskierka-Jazdzewska, T Robak A systematic review and meta-analysis of B-cell receptor signaling inhibitors in relapsed and refractory chronic lymphocytic leukemia LEUKEMIA & LYMPHOMA 2017:58, 152-153 [citations: 0]
- M Zakrzewska, W Fendler, K Stawiski, R Gruszka, K Zakrzewski, … Comparative Analysis of miRNA Expression in Pediatric Neuronal and Mixed Neuronal-Glial Tumors PEDIATRIC BLOOD & CANCER 2017:64, S318-S318 [citations: 0]
- LJ Lee, BE Howitt, W Fendler, K Stawiski, P Bu, L Cho, D Chowdhury, … miRNA profiling in a case: Control study of African American women with uterine serous carcinoma (USC). Journal of Clinical Oncology 2017:35 (15_suppl), e17116-e17116 [citations: 0]
- KM Elias, WF Fendler, K Stawiski, A Vitonis, RS Berkowitz, DW Cramer, … Serum MicroRNA Sequencing for Early Diagnosis of Invasive Ovarian Cancer. REPRODUCTIVE SCIENCES 2017:24, 87A-87A [citations: 0]
- A Puła, KG Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak Bezpieczeństwo i efektywność kliniczna nowych inhibitorów szlaku sygnałowego receptorów limfocytów B w leczeniu nawrotowej i opornej przewlekłej białaczki limfocytowej … Acta Haematologica Polonica 2017:48 (Supl. 1) [citations: 0]
- Ł Dziki, A Puła, K Stawiski, B Mudza, M Włodarczyk, A Dziki Patients’ awareness of the prevention and treatment of colorectal cancer Polish Journal of Surgery 2015:87, 459-463 [citations: 16]
- K Stawiski, A Strzałka, A Puła, K Bijakowski PancreApp: an innovative approach to computational individualization of nutritional therapy in chronic gastrointestinal disorders MEDINFO 2015:2015: eHealth-enabled Health, 325-328 [citations: 10]
- A Strzałka, K Stawiski, A Kaczmarek, A Kuchareczko, M Polguj, M Topol Analiza zmienności morfologicznych i topograficznych w zakresie struktur nerwowych i mięśniowych jamy pachowej (axillary fossa) w kontekście ich ewentualnych implikacji klinicznych Wydawnictwo Uniwersytetu Medycznego w Gdańsku 2013: [citations: 0]
- Ł Kuncman, M Orzechowska, K Stawiski, M Masłowski Ciazy nska, M Gottwald, L NA: [citations: 4]
- K Stawiski, J Perera‐Bel, A Rodriguez‐Vida, N Juanpere, J Lee, … Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma Molecular Oncology NA: [citations: 0]
- K Stawiski, Ł Kuncman, M Jobczyk, M Bilski, C Franzese, M Orzechowska, … Pre-Treatment Sacral Bone Geometry Predicts Radiation-Induced Lymphopenia in Prostate Cancer Available at SSRN NA:650635 [citations: 0]
- K Elias, U Smyczynska, K Stawiski, Z Nowicka, J Webber, J Kaplan, … Identification of BRCA1/2 mutation female carriers using circulating microRNA pro les screening NA:10, 1 [citations: 0]
See the details on PubMed: http://link.konsta.com.pl/pubmed
Not-indexed conference posters and awards were not included here.
Book chapters
- Konrad Stawiski, Łukasz Polak, Wojciech Fendler, Jarosław Drożdż. Evidence-based medicine w kardiologii. WIELKA INTERNA: Kardiologia część 1 - wydanie II. Medical Tribune Polska 2018.
- Konrad Stawiski, Jacek Fijuth. Sztuczna inteligencja w onkologii. Innowacyjna Onkologia: potrzeby, możliwości, system. PZWL 2020. ISBN 978-83-200-6032-4
Teaching and invited lectures
- 2023: “Odmienne twarze Greja – dawki biologicznie równoważne w zależności od sposobu frakcjonowania i lokalizacji anatomicznej”. Konferencja “Radioterapia stereotaktyczna w dobie leczenia celowanego” [Polish]
- 2023: “Wyniki badania klinicznego – analiza oraz ocena wartości” (Clinical trial results - analysis and value assessment) as part of the postgraduate studies “Non-commercial Clinical Research - Design, Implementation and Management” (Wroclaw Medical University)
- 2022: “Czy sztuczna inteligencja zastąpi człowieka w planowaniu leczenia promieniami? (Will artificial intelligence replace humans in radiation treatment planning?)”, X Zjazd Polskiego Towarzystwa Radioterapii Onkologicznej, Łódź
- 2022: “Deep artificial neural networks in the integration of the expression profile of circulating and intracellular miRNA particles in pancreatic cancer patients.” Lodz Oncology Days
- 2022: “Application of advanced statistical tools and artificial intelligence in prognosis and response prediction to treatment in prostate cancer”. Rak Stercza - Wielodyscyplinarne Podejście Do Terapii Po Niepowodzeniu Leczenia Miejscowego I W Chorobie Z Przerzutami
- 2022: “Time series analysis” as part of postgraduate studies “Elements of empirical research methodology in medicine and application of statistics in biomedical research” (Medical University of Lodz)
- 2022: “Introduction to Data Mining methods and the STATISTICA Data Miner system” as part of postgraduate studies “Elements of empirical research methodology in medicine and the application of statistics in biomedical research” (Medical University of Lodz)
- 2021-2022: “Data in clinical trials (CRF) and database management.” as part of the postgraduate studies “Non-commercial Clinical Research - Design, Implementation and Management” (Wroclaw Medical University)
- 2021-2022: “New Technologies in Clinical Trials. Big Data.” as part of postgraduate studies “Non-commercial clinical research - design, implementation and management” (Medical University in Wrocław)
- 2021: “Biostatistics workshops” as part of the initiative of the Young Division of the Polish Society of Radiation Oncology
- 2019: “Deep teaching as a technique to increase the effectiveness of molecular biomarkers” 9th Congress of the Polish Society of Radiation Oncology
- 2018: “Data mining to discover ovarian cancer signature in the miRNA serum profile” Elias Lab Meeting at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Boston, USA
- 2018: “From anatomy to artificial intelligence in oncology” Local “I’m gonna be a scientist” conference.
Commercial clinical trials
Own open source IT projects
- RTpipeline [6★] RTpipeline - research-grade pipeline transforming raw DICOM radiotherapy exports into analysis-ready data for radiotherapy, radiomics, dose-volume histogram (DVH), and machine-learning workflows (documentation).
- Somatic Likelihood Tiering [1★] Somatic Likelihood Tiering (SLT) - interpretable multi-evidence framework for tumor-only whole-exome sequencing variant triage (Zenodo DOI).
- Prostate AS-counselling calculators [0★] Open-access active-surveillance counselling calculator estimating biopsy-to-prostatectomy ISUP-upgrade risk (Jobczyk et al. 2026).
- OmicSelector [34★] OmicSelector - Environment, docker-based application, and R package for biomarker signature selection (feature selection) & deep learning model development from high-throughput omics experiments and other multidimensional datasets. Initially developed for miRNA-seq, RNA-seq, and qPCR.
- seq-pipeline [10★] Workspace for data science projects and NGS pipelines by Konrad Stawiski.
- OmicApp [3★] Shiny Complex App framework with OmicSelector for all purposes.
- neurexam [0★] Neurexam (Neurological Study by Konrad Stawiski) - interactive neurological examination assistant and electronic health record.
- [https://github.com/kstawiski/pancreapp] [0★] PancreApp is an innovative approach to computational individualizing nutritional therapy in chronic gastrointestinal disorders.
Certified courses
- 2022: Single-cell RNA-seq data analysis workshop, Harvard Chan Bioinformatics Core (HBC), Boston, MA, USA
- 2022: Bulk RNA-seq data analysis workshop (part 1 and 2), Harvard Chan Bioinformatics Core (HBC), Boston, MA, USA
- 2016: “Computational Genomics” (Summer School), Max-Delbrück-Centre for Molecular Medicine, Berlin, Germany
- 2016: “Fundamentals of Digital Image and Video Processing” (Coursera ID: ULTLWMZSCYEZ), Northwestern University , Evanston, IL, USA
Skills
- Programming: R (advanced; data processing, statistical analysis, application programming, data mining), python (basic; data mining), C# .NET (advanced; C# .NET WinForms desktop applications), PHP (intermediate; website development using CMS WordPress, creating applications using Bootstrap)
- Bioinformatics and medical informatics. In particular, analysis of next-generation sequencing data and other large-scale data.
- Data analysis (data science and biostatistics; knowledge of STATISTICA, MedCalc, IBM SPSS; data mining using R and python and Weka)
- Medical image analysis (knowledge of 3D Slicer, ITK SNAP, pyRadiomics)
- Linux knowledge with server configuration: knowledge of bash; docker; services (apache2/nginx, php, e-mail, ftp); cybersecurity - SSH tunneling, ufw, fail2ban.
- The basics of Windows Server configuration.
Organizational activity
- 2021 - present: Member of ESTRO (European Society for Radiotherapy and Oncology);
- 2019 - present: Member of the Polish Oncological Society;
- 2019 - present: Member of the Polish Society of Radiation Oncology;
- 2017 - 2018: Member of the program council, Kuźnia Młodych Talentów, Academy of Young Scholars of the Polish Academy of Sciences.
- 2014 - 2016: Individual Course of Studies at the Department of Biostatistics and Translational Medicine; tutor: Dr Wojciech Fendler;
- 2013 - 2015: President of the Student Scientific Society of the Medical University of Lodz.
- 2012 - 2013: Member of the Board of the Student Scientific Society of the Medical University of Lodz.
- 2012 - 2013: Individual Course of Studies at the Department of Neurosurgery and Oncology of the Nervous System; tutor: Dr Krzysztof Tybor;
- 2012 - 2015: Member of the Student Scientific Society at the Department of Neurosurgery;
- 2011 - 2015: Member of the Student Research Group at the Faculty of Normal and Clinical Anatomy;
- 2011 - 2015: International Association of Medical Students (IFMSA): (1) 2014: European Regional Meeting of Medicine Students, General Delegate of Poland, (2) 2013 - 2016: IFMSA New Technologies Support Division Director Assistant (international position), (3) 2013 - 2015: Member of the IFMSA-Poland marketing team (national position), (4) 2013 - 2015: IFMSA-Poland National New Technologies Director (national position), (5) 2012 - 2013: IFMSA-Poland National New Technologies Director Assistant (national position), (6) 2012 - 2013: Local coordinator of the project “Dying - a human thing” (local position), (7) 2011 - 2014: Local New Technologies Director (local position), (8) participation in 3 national IFMSA-Poland assemblies (Fall 2012, Spring 2012, Fall 2013).
This CV was generated on 2026-07-06.
Copyright © 2026 Konrad Stawiski (konrad@konsta.com.pl; konrad@stawiski.net). Built as OmicApp by Konrad Stawiski.